946511-98-4 Usage
Uses
Used in Organic Chemistry:
(S)-1-(neopentyloxy)-1-oxopropan-2-aminium chloride is used as a reagent for various chemical reactions in the field of organic chemistry. Its unique structure allows it to participate in a range of reactions, making it a valuable tool for chemists.
Used in Pharmaceutical and Medicinal Products:
In the pharmaceutical industry, (S)-1-(neopentyloxy)-1-oxopropan-2-aminium chloride is employed as a building block for the synthesis of more complex molecules with potential medicinal properties. Its versatility and stability contribute to its utility in drug development.
Used in Research and Development:
(S)-1-(neopentyloxy)-1-oxopropan-2-aminium chloride is also used as a research tool to explore new chemical reactions and develop novel synthetic pathways. Its application in research and development aids in the advancement of scientific knowledge and the creation of new chemical entities with potential applications in various industries.
Overall, (S)-1-(neopentyloxy)-1-oxopropan-2-aminium chloride is a versatile and valuable chemical compound with a wide range of applications in organic chemistry, pharmaceuticals, and research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 946511-98-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,6,5,1 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 946511-98:
(8*9)+(7*4)+(6*6)+(5*5)+(4*1)+(3*1)+(2*9)+(1*8)=194
194 % 10 = 4
So 946511-98-4 is a valid CAS Registry Number.
946511-98-4Relevant academic research and scientific papers
ANTIVIRAL COMPOUNDS
-
Paragraph 0224, (2021/08/27)
The present disclosure describes 4'-fluoromethyl nucleosides for treating viral infections, including Dengue.
ANTIVIRAL COMPOUNDS
-
Paragraph 0472, (2021/08/27)
The present disclosure provides compounds for treating a variety of diseases, such as respiratory syncytial virus (RSV), HRV, hMPV, ebola, Zika, West Nile, Dengue, and HCV.
NUCLEOTIDE PRODRUGS
-
Paragraph 0143; 0144, (2019/07/20)
The invention relates to nucleotide prodrugs and pharmaceutical preparations thereof. The invention further relates using the prodrugs of the invention in the treatment of mitochondrial DNA (mtDNA) depletion syndrome (MDS).
NUCLEIC ACID PRODRUGS
-
Page/Page column 35; 36, (2017/08/04)
The invention relates to nucleotide prodrugs and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel prodrugs of the invention.